Viatris Settles EpiPen Antitrust Litigation for $264 Million

The proposed settlement, which requires a judge’s approval, would resolve a legal battle that began after the company, in 2016, raised the price for two EpiPens to $608 from $100.

from NYT > Health https://ift.tt/pl2FAjb
via health&fitness